Patent US4923963A successfully refreshed from Google Patents.
US4923963A
Copy Number
Expired / Lapsed
US
⏱️ 0.0 years remaining
Bradykinin antagonist peptides
Assignee: NOVA TECHNOLOGY A CORP OF LP
•
Filing: 1987-09-02
•
Granted: 1990-05-08
•
Expires: 2007-09-02
Overview & Biblio
Claims (12)
Citations (3)
Maintenance Schedule (3)
Categories & Tags (0)
Abstract
Abstract The substitution of the L-Pro at the 7-position of the peptide hormone bradykinin or other substituted analogs of bradykinin with an aliphatic, cyclic or aromatic amino acid of the D-configuration converts bradykinin agonists into a bradykinin antagonist. The invention further includes additional modifications at other positions within the novel 7-position modified bradykinin antagonists including C-terminal and N-terminal extensions and replacement of arginine in the one and nine positions which increase enzyme resistance, antagonist potency and/or specificity of the new bradykinin antagonists. The analogs produced are useful in treating conditions and diseases of the mannal and human body in which an excess of bradykinin or related kinins are produced or injected as by bites into the body.
Inventors
👤 John M. Stewart
👤 Raymond J. Vavrek
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-08 14:39
CPC Classifications
C; C07; C07K; C07K7/00; C07K7/04; C07K7/18; A; A61; A61P; A61P1/00; A61P1/12; A61P11/00; A61P17/00; A61P25/00; A61P25/04; A61P29/00; A61P37/00; A61P37/08; A61P9/00; A61P9/02; A61K; A61K38/00
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
6 words
The peptide having the formula CDF-Pro-Pro-Gly-Phe-Ser-DPhe-Phe-Arg.
Claim 2
Dependent Claim
6 words
The peptide having the formula CDF-Pro-Pro-Gly-Phe-Ser-DPhe-Phe-Arg.
Claim 3
Dependent Claim
6 words
The peptide having the formula DArg-CDF-Pro-Hyp-Gly-Phe-Ser-DPhe-DPhe-Arg.
Claim 4
Dependent Claim
6 words
The peptide having the formula DArg-CDF-Pro-Hyp-Gly-Phe-Ser-DPhe-DPhe-Arg.
Claim 5
Dependent Claim
6 words
The peptide having the formula DArg-FDF-Pro-Hyp-Gly-Thi-Ser-DPhe-Phe-Arg.
Claim 6
Dependent Claim
6 words
The peptide having the formula DArg-FDF-Pro-Hyp-Gly-Thi-Ser-DPhe-Phe-Arg.
Claim 7
Dependent Claim
6 words
The peptide having the formula DArg-Arg-Pro-Pro-Gly-Thi-Ser-DPhe-Thi-Phe-Ile-Tyr.
Claim 8
Dependent Claim
6 words
The peptide having the formula DArg-Arg-Pro-Pro-Gly-Thi-Ser-DPhe-Thi-Phe-Ile-Tyr.
Claim 9
Dependent Claim
6 words
The peptide having the formula Ac-Arg-Pro-Pro-Gly-Thi-Ser-DPhe-Thi-Phe-Ile-Tyr.
Claim 10
Dependent Claim
6 words
The peptide having the formula Ac-Arg-Pro-Pro-Gly-Thi-Ser-DPhe-Thi-Phe-Ile-Tyr.
Claim 11
Dependent Claim
6 words
The peptide having the formula DArg-DArg-Pro-Hyp-Gly-Phe-Ser-DPhe-Phe-Phe.
Claim 12
Dependent Claim
6 words
The peptide having the formula DArg-DArg-Pro-Hyp-Gly-Phe-Ser-DPhe-Phe-Phe.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
Annuity Stage
Window Opens
Payment Deadline
Surcharge Period Until
Estimated Fee
Status
3.5 Years (Year 4)
1993-05-07
1993-11-06
1994-05-08
$2000.00
Window Closed / Lapsed
7.5 Years (Year 8)
1997-05-07
1997-11-06
1998-05-08
$3760.00
Window Closed / Lapsed
11.5 Years (Year 12)
2001-05-07
2001-11-06
2002-05-08
$7700.00
Window Closed / Lapsed